🟢 $JNCE Target 12.34 for 76.03% Or double position at 1.68 Biotech is the shadiest sector to trade, but I love it. Ok, maybe not shady... just volatile. — On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average. I start every position with 1% of my account and build from...
TARGET HIT @ 13.76 for 14.76% Profit I took profits today. . . The target was set when I bought it 31 days ago. GL to those who sell higher…
First off, please don't take anything I say seriously or as financial advice. As always, this is on opinion based basis. That being said, here are my insights. JNCE is expected to go up quite soon and is on breakout watch. My recommendation based off of current charting patterns and past wave correlations is to buy now and set a sell order at a $6.50 price target...
Jounce Therapeutics Inc (NASDAQ: JNCE) shares are trading higher after the company announced an amended licensing agreement with Celgene Corporation (NASDAQ: CELG), the latter of which has agreed to be acquired by Bristol-Myers Squibb Co (NYSE: BMY). (Source: finance.yahoo.com) Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which treat...